A randomized phase II neoadjuvant trial in patients with stage II-III and inflammatory breast cancer

被引：0
|
作者：
Somlo, G. [1 ]
Paz, B. [1 ]
Shen, J. [1 ]
Garberoglio, C. [1 ]
Luu, T. [1 ]
Chung, C. [1 ]
Hurria, A. [1 ]
Frankel, P. [1 ]
Baker, N. [1 ]
Wilczynski, S. [1 ]
Arnold, K. [1 ]
Yeb, Y. [1 ]
机构：
[1] City Hope Comprehens Canc Ctr, Duarte, CA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [1] Metformin with neoadjuvant chemotherapy in stage II-III breast cancer: A phase II clinical trial
    Azazy, H. A.
    Gado, N. M.
    Salem, D. A.
    El-Ghamry, W. R.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S323 - S324
  • [2] Neoadjuvant combination for stage II-III breast cancer
    Bagchi, Sanjit
    [J]. LANCET ONCOLOGY, 2007, 8 (07): : 579 - 579
  • [3] Neoadjuvant biweekly chemotherapy with liposomal doxorubicin and docetaxel in patients with stage II-III breast cancer
    Alvarez, I
    Modolell, A.
    Mayordomo, J., I
    Heras, L.
    Villadiego, K.
    Rolfo, C. D.
    Garcia-Bueno, J. M.
    Pica, P.
    Murillo, L.
    Morales, S.
    Valera, P.
    Florian, J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [4] Predictors of Recurrences in Stage II-III Breast Cancer in Patients Receiving Neoadjuvant Systemic Therapy
    Dayyat, A.
    Mheid, S.
    Erjan, A.
    AlHammadi, A.
    Alnsoor, A.
    Abdelrahman, F.
    Al Masri, H.
    Al-Rashdan, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E2 - E2
  • [5] Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer
    Ramaswamy, B
    Povoski, SP
    Rhoades, C
    Allen, J
    Hauger, M
    Young, D
    Burak, W
    Farrar, W
    Yee, L
    Kendra, K
    Somasundaram, S
    Orlowski, RZ
    Shapiro, CL
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 93 (01) : 67 - 74
  • [6] Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer
    Bhuvaneswari Ramaswamy
    Steven P Povoski
    Chris Rhoades
    Joan Allen
    Marsha Hauger
    Donn Young
    William Burak
    William Farrar
    Lisa Yee
    Kari Kendra
    Sivagurunathan Somasundaram
    Robert Z Orlowski
    Charles L. Shapiro
    [J]. Breast Cancer Research and Treatment, 2005, 93 : 67 - 74
  • [7] Neoadjuvant Treatment Approaches for Stage II-III Rectal Cancer
    Nurkin, Steven
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 572 - 575
  • [8] Neoadjuvant trastuzumab in a sequential nonanthracycline-based regimen for patients with stage II-III breast cancer
    Carillio, G.
    Aiello, R.
    Ali, M.
    Mazzola, A.
    Scandurra, G.
    Taibi, E.
    Chiarenza, M.
    Fallica, G.
    Caruso, F.
    Caruso, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Role of Postmastectomy Radiation After Neoadjuvant Chemotherapy in Stage II-III Breast Cancer
    Fowble, Barbara L.
    Einck, John P.
    Kim, Danny N.
    McCloskey, Susan
    Mayadev, Jyoti
    Yashar, Catheryn
    Chen, Steven L.
    Hwang, E. Shelley
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : 494 - 503
  • [10] Neoadjuvant chemotherapy for stage II-III breast cancer: a single-center experience
    Zaher, Haidi Abd El
    Fathy, Hamada
    Abozeid, Mohamed
    Faisal, Mohammed
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
12345